VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1067958
Sex: F
Age:
State: WI

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: I experienced Abdominal cramping, chills, and diarrhea onset within 3 hours of vaccine administration; I experienced Abdominal cramping, chills, and diarrhea onset within 3 hours of vaccine administration; I experienced Abdominal cramping, chills, and diarrhea onset within 3 hours of vaccine administration; left arm soreness onset evening of vaccine for about 1.5 days; This is a spontaneous report from a contactable nurse (also the patient). A 51-year-old female (also the age at vaccination) patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL3248), via an unspecified route of administration at the left arm on 07Jan2021 14:40 (also reported as 02:45 PM) at SINGLE DOSE for Covid-19 immunization. The patient was vaccinated at a Hospital. The patient is not pregnant at the time of the report. Medical history included Environmental allergies: some trees and grass (also reported as Known allergies: No). The patient had no COVID prior to vaccination. Th patient was not COVID tested post vaccination. No other vaccine in four weeks. Concomitant medication included (reported as Other medications in two weeks) bupropion hydrochloride (WELLBUTRIN), loratadine, pseudoephedrine sulfate (CLARITIN-D), montelukast sodium (SINGULAIR), diphenhydramine hydrochloride (BENADRYL), vitamin d nos (VITAMIN D NOS) and MVM (exact meaning unspecified). It was reported that: "Administration time on my paperwork was documented incorrectly; I received 07Jan2021 dose at 2:40pm and not the 1:40pm time that is documented. I experienced Abdominal cramping, chills, and diarrhea onset within 3 hours of vaccine administration (reported as 5:30 PM), lasting about 2 hours and resolved; left arm soreness onset evening of vaccine for about 1.5 days." The patient was not treated for the events. The outcome of the events was recovered.

Other Meds: WELLBUTRIN; CLARITIN-D; SINGULAIR; BENADRYL; VITAMIN D NOS

Current Illness:

ID: 1067959
Sex: F
Age:
State: NJ

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: face started to feel "hot and on fire"; face and neck turned bright red; face started to feel really tight; Heart Rate then was elevated to 115 bpm; shortness of breath; itchy eyes; headache; nausea; Arm still felt sore; fatigued; At site of injection there was a warm sensation; metallic taste in my mouth; This is a spontaneous report from a contactable nurse (patient). A 41-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262) solution for injection, intramuscular at left arm on 29Jan2021 at 10:30 AM at single dose for COVID-19 immunization. Medical history included asthma. The patient has no known allergies. The patient's concomitant medications were not reported. The patient was not pregnant and has no other vaccines in four weeks. She will have a birth control in two weeks. It was unknown if the patient has COVID prior to vaccination. She was not tested with COVID post vaccination. The patient was given COVID-19 vaccine at a hospital. When she initially received the vaccine on 29Jan2021, the site of injection had a warm sensation which resolved within a minute. Then on the ride home, she had a metallic taste in her mouth. While at home around 4:00 PM, her face started to feel hot and on fire and then her face and neck turned bright red. Her face started to feel really tight and hot. Heart rate was then elevated to 115 bpm. She then started having shortness of breath, itchy eyes, headache and nausea. The patient sat down and took 10 mL of BENEDRYL (as reported) at 4:30 PM or 4:40 PM. Between 5:00 PM and 7:00 PM, her face and neck were still slightly red. Her arm felt sore and she was fatigued. She again took 10 mL of BENEDRYL at 7:30 PM. She woke up on 30Jan2021 and still felt fatigued and the back of arm (tricep area) was very sore. The patient also took paracetamol (TYLENOL) 600 mg. The outcome of the event vaccination site warmth was recovered with sequel on 29Jan2021 and recovered with sequel on Jan2021 for all other events.

Other Meds:

Current Illness:

ID: 1067960
Sex: M
Age:
State: LA

Vax Date:
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: has been on immunotherapy for lung cancer; has been on immunotherapy for lung cancer; off-balance weakness/off-balance; off-balance weakness; feeling tired/fatigue; sleeping a lot; This is a spontaneous report from a contactable consumer (patient's wife). A male patient (husband) of an unspecified age (Age: 78, Units: Unknown) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date: not known), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history included the patient had been on immunotherapy for lung cancer for almost a year and it had been working and shrinking everything; took the chemo prior but stopped because of his feet as it gave him neuropathy so he only took 3; and neuropathy (he was fantastic prior to the shot with the only symptom being his feet neuropathy). Historical vaccine included first dose of BNT162B2 on an unspecified date for COVID-19 immunization (took the first dose of Pfizer COVID-19 vaccine and he was fine). The reported stated after the patient's second dose (unspecified date), he was feeling tired and sleeping a lot since this past Saturday (30Jan2021). Upon recent follow-up, the reporter asked if how long side effects last and if anyone had a reoccurrence of symptoms. The reporter was calling regarding her husband who had the second dose of vaccine and the patient had symptoms: fatigue and tiredness and it went away in a day and a half, but then he had a reoccurrence, after 2-3 days. On 04Feb2021, the patient had off-balance weakness. Yesterday morning (04Feb2021), he got up and was really off-balance. The nurse said it should subside in 1-2 days, and it did but then he had a reoccurrence. She stated he had been on immunotherapy for lung cancer for almost a year and it had been working and shrinking everything. The patient received the vaccine at (name) in (state name). The caller asked if there was an interaction with the immunotherapy and the vaccine. And also, asked if the patient should have not gotten the vaccine. She stated she will call the doctor after the call. The caller stated at the nursing home, not one person had a reaction with the second shot. The outcome of the events feeling tired/fatigue, sleeping a lot, and "off balance weakness" was not recovered. Information about Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 1067961
Sex: F
Age:
State: OH

Vax Date: 01/28/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: diarrhea; injection site pain; tiredness; headache; muscle pain; chills with elevated temp; chills with elevated temp; joint pain; injection site swelling and redness; injection site swelling and redness; nausea; feeling unwell; This is a spontaneous report from a contactable consumer (patient). An 83-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9265), via an unspecified route of administration at the left arm on 28Jan2021 at 08:00 AM (at age of 83 years old) at a single dose for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The facility where the most recent COVID-19 vaccine was administered was reported as "Other". The patient's medical history included stage 3 kidney, prediabetes, and allergies to sulfa. The patient was not diagnosed with COVID-19 prior to vaccination. The patient received unspecified concomitant medications (patient received other medications within 2 weeks of vaccination). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took hypromellose (GENTEAL; reported as "gen-teal") and experienced allergy. On 29Jan2021 at 02:00 AM, the patient experienced diarrhea, injection site pain, tiredness, headache, muscle pain, chills with elevated temp, joint pain, injection site swelling and redness, nausea, and feeling unwell. The patient did not receive treatment for the events. The patient has not been tested for COVID-19 since the vaccination. The events were reported as non-serious. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 1067962
Sex: M
Age:
State: NV

Vax Date: 01/27/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Sore throat; chills; headache; lower back pain; muscle pain; sinus drainage; severe cough; This is a spontaneous report from a contactable consumer (patient). A 64-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EL9262), via an unspecified route of administration on the right arm on 27Jan2021 09:30 at a single dose for COVID-19 immunisation. Medical history included hypertension. The patient has no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan, atenolol, and atorvastatin. The patient experienced sore throat, chills, headache, lower back pain, muscle pain, severe cough with thick yellow phlegm on 29Jan2021 13:00. It was reported that the patient had sinus drainage on 29Jan2021 13:00. There was no treatment for the events. The patient has not recovered from the events yet.

Other Meds: LOSARTAN; ATENOLOL; ATORVASTATIN

Current Illness:

ID: 1067963
Sex: F
Age:
State: PA

Vax Date: 01/21/2021
Onset Date: 01/28/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Lip tingling/fizzing; This is a spontaneous report from a contactable nurse (patient). A 42-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL 3246), via an unspecified route of administration (at the age of 42-years-old) on 21Jan2021 10:00 at a single dose in right arm for COVID-19 immunization. Medical history included none. No allergies to medications, food, or other products. Concomitant medication included rosuvastatin calcium (CRESTOR), spironolactone, tacrolimus, and macrogol 3350 (MIRALAX). The patient experienced lip tingling/fizzing on 28Jan2021 19:00 with outcome of recovering. No treatment received for the adverse event. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered was Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The event was considered as non-serious.

Other Meds: CRESTOR; SPIRONOLACTONE; TACROLIMUS; MIRALAX

Current Illness:

ID: 1067964
Sex: F
Age:
State: MD

Vax Date: 01/30/2021
Onset Date: 01/01/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: injection site/arm soreness/just the area around the needle site/Just tender; This is a spontaneous report received from a Pfizer-sponsored program, Pfizer First Connect. A contactable consumer (reported for herself) reported that a female patient of an unspecified age (age: 82; unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date: not known), via an unspecified route of administration on 30Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Jan2021, the patient mentioned "injection site/arm soreness". The patient said it was just the area around the needle site. Just tender. It was not extremely sire, it was tender sore. The patient was asking if how she would know if they will get a hematoma after the vaccine and if she should expect anything and the patient was made aware of signs of potential hematoma with redness, swelling, pain or bruising. The patient was referred to speak with healthcare professional (HCP) if she believes there is a hematoma or concerns about potential hematoma forming. The outcome of the event was unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 1067965
Sex: M
Age:
State: CA

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: the onset of blurred vision in one eye and flashing colored lights in both eyes.; the onset of blurred vision in one eye and flashing colored lights in both eyes.; This is a spontaneous report from a contactable physician (patient). A 78-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262), intramuscular at the left arm on 21Jan2021 08:45 at single dose for COVID-19 immunization. Medical history included Parkinson's and neuropathy. The patient has allergies to CIPRO antibiotics. Concomitant medication included unspecified multiple supplements. On 22Jan2021 at 09:00 (24 hours after vaccination), the patient had the onset of blurred vision in one eye and flashing colored lights in both eyes. This was unlike anything he has ever experienced, and it persisted for several hours. Vision gradually returned to normal and lights disappeared. This was not a retinal detachment or vitreous detachment. It was not associated with eye pain. The patient did not receive any treatment for the events. The patient recovered from the events on an unspecified date in 2021.

Other Meds:

Current Illness:

ID: 1067966
Sex: F
Age:
State: WI

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: just a sore arm starting approx 6 hours after injection; This is a spontaneous report from a contactable healthcare professional (patient). A 51-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EL3249; expiration date: unknown) at vaccination age of 51-year-old intramuscular in the right arm on 15Jan2021 10:00 at a single dose for covid-19 immunization. Medical history included high blood pressure, and allergies to penicillin and sulfa. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included unspecified medication. The patient received her most recent COVID-19 in a public health clinic/veterans administration facility. The patient reported that she did no adverse events, she was just a sore arm starting approximately 6 hours after injection (15Jan2021) and lasting about 24 hours (16Jan2021). The event was non-serious. The patient has not been tested for COVID-19 since the vaccination. The outcome of the event was recovered on 16Jan2021. No follow up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1067967
Sex: M
Age:
State: FL

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Face flush for 6 hours; This is a spontaneous report from a non-contactable consumer. A 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose, lot number and expiration date unknown, via an unspecified route of administration at the age of 67 years on 25Jan2021 11:30 at single dose in the left arm for COVID-19 immunization. Medical history included mild hypertension. The patient had no allergies to medications, food, or other products. Prior vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included rosuvastatin, losartan and hctz. The patient experienced face flush (non-serious) for 6 hours on 25Jan2021 11:45. There was no treatment for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient has not been tested for COVID-19 since vaccination. The outcome of the event was recovered. No follow-up attempts are possible, information about batch number cannot be obtained.

Other Meds: ROSUVASTATIN; LOSARTAN; HCTZ

Current Illness:

ID: 1067968
Sex: M
Age:
State: HI

Vax Date: 01/30/2021
Onset Date: 01/31/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Headache; Pain at injection site; Swollen injection site; Fatigued; This is a spontaneous report from a contactable consumer (patient). A 30 -year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL9626), via an unspecified route of administration (on the left arm) on 30Jan2021 16:15 (at the age of 30-years-old), single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included amlodipine;olmesartan, lorazepam. The patient experienced Headache,Pain at injection site, Swollen injection site, Fatigued, all on 31Jan2021. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 06Jan2021 Nasal Swab (reported as post vaccination). No treatment received for the adverse events. The outcome of the events was not recovered. Prior to vaccination, it is unknown if the patient diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19 (date of test reported as 06Jan2021). The reporter assessed the events as non-serious.

Other Meds: AMLODIPINE;OLMESARTAN; LORAZEPAM

Current Illness:

ID: 1067969
Sex: F
Age:
State: NJ

Vax Date: 01/26/2021
Onset Date: 01/31/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Fever; This is a spontaneous report from a contactable consumer (patient herself). A 47-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EL 9262, expiration date was unknown), via an unspecified route of administration on 26Jan2021 at 08:30 AM at a single dose for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was reported as the hospital. The patient's medical history was not reported. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Jan2021 at 11:00 AM, the patient experienced fever. The patient assessed the event as non-serious. The patient did not receive any treatment for the adverse event. The patient was not recovered from the event.

Other Meds:

Current Illness:

ID: 1067970
Sex: M
Age:
State: CA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: sciatic nerve diagnosed as inflamed only left leg and shot provided left arm; This is a spontaneous report from a contactable nurse (patient). A 62-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration in right arm on 08Jan2021 14:00 at a single dose for Covid-19 immunization. Medical history included blood pressure. Concomitant medication included unspecified blood pressure medication. On 09Jan2021 at 2pm, sciatic nerve was diagnosed as inflamed only on left leg and shot (treatment) was provided in left arm. Patient visited emergency room/department, methylprednisolone sodium succinate (PF) was given as treatment. The event was reported as non-serious, patient was not hospitalized. The patient underwent lab tests which included COVID-19 Nasal RT-PCR: negative on 25Jan2021 (Nasal Swab). Outcome of the event was recovering. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1067971
Sex: U
Age:
State: NC

Vax Date: 01/15/2021
Onset Date: 01/17/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Right arm remains red; Sweats profusely; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (BNT162B2; Lot number and expiry date not reported) via an unspecified route of administration to right arm from 15Jan2021 at 09:00 at single dose for covid-19 immunization. Medical history included arthritis from an unknown date. There were no concomitant medications. The patient experienced Right arm remains red and sweats profusely on 17Jan2021 at 12:00 AM. The events were reported as non-serious. No treatments were received for the reported events. The outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1067972
Sex: F
Age:
State: NY

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: the vision in my right eye became blurry; This is a spontaneous report from a contactable consumer (patient herself). A 78-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: el9262), via an unspecified route of administration in the left arm on 26Jan2021 09:00 at a single dose for COVID-19 immunization. The patient had no relevant medical history and no known allergies. Concomitant medication included metoprolol succinate (TOPROL 25 mg) received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She previously received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: el3246), via an unspecified route of administration in the left arm on 05Jan2021 11:30 for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. She was not pregnant. The patient experienced "the vision in my right eye became blurry" on 26Jan2021 09:15. The patient reported that the event was "still is" as date of the report. The event was reported as non-serious and resulted in doctor or other healthcare professional office/clinic visit. The outcome of the events was not recovered. The patient had not been tested for COVID-19 since the vaccination.

Other Meds: TOPROL

Current Illness:

ID: 1067973
Sex: F
Age:
State: MD

Vax Date: 01/26/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: sudden rash appear on left side of my chest and shoulder, just visually a bunch of red dots; Swollen lymph nodes, both collar bone and neck; This is a spontaneous report from a contactable consumer (patient). A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283), via an unspecified route of administration at the left arm on 26Jan2021 at single dose for COVID-19 immunisation. The patient has no medical history. The patient was not pregnant at the time of vaccination. Concomitant medication included ethinylestradiol, levonorgestrel (LUTERA). The patient experienced swollen lymph nodes, both collar bone and neck noticed the evening of 30Jan2021. Expected as much for an immune response, but then she had a sudden rash appear on left side of her chest and shoulder, just visually a bunch of red dots, no itching or discomfort the afternoon of 31Jan2021. She was reporting immediately, so no recovery yet. The patient did not receive any treatment for the events. The patient has not recovered from the events.

Other Meds: LUTERA

Current Illness:

ID: 1067974
Sex: F
Age:
State: NJ

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: experience left arm pain radiating from my shoulder down to my fingers; experience left arm pain radiating from my shoulder down to my fingers; left arm weakness; This is a spontaneous report from a contactable physician (patient). A 65-year-old non-pregnant female patient received her second dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EJUe85; expiration date: unknown) at vaccination age of 65-year-old intramuscularly in the left arm on 20Jan2021 10:30 at a single dose for covid-19 immunization. The patient's medical history was none. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has no allergies to medications, food, or other products. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EJUe85) at vaccination age of 65-year-old intramuscularly in the left arm on 30Dec2020 at a single dose for covid-19 immunization. The patient received the most recent COVID-19 vaccine in a hospital. On 21Jan2021 after the second Pfizer dose (24 hours after the injection), she began to experience left arm pain radiating from her shoulder down to her fingers. The pain was sharp, constant and associated with left arm weakness. This has persisted for 10 days with no relief and she was still experiencing this pain now. The events were considered as non-serious and did not require treatment. The patient has not been tested for COVID-19 since the vaccination. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 1067975
Sex: F
Age:
State: NC

Vax Date: 01/14/2021
Onset Date: 01/16/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: dizziness; achiness behind my eyes for 16 days; This is a spontaneous report from a contactable healthcare professional (patient). A 45-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231), via an unspecified route of administration at the left arm on 14Jan2021 at 12:30 PM at a single dose for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was a hospital. The patient was not pregnant at the time of vaccination. The patient's medical history included penicillin allergy. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162B2 (lot number: EK5730) on 26Dec2020 at 03:30 PM (at the age of 45 years old) at the left arm for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. On 16Jan2021 at 09:00 AM, the patient experienced dizziness and achiness behind her eyes for 16 days. The patient did not receive treatment for the events. The events were reported as non-serious. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient has been tested for COVID-19 which included Nasal Swab: Negative on 31Jan2021. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 1067976
Sex: M
Age:
State: MI

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Nausea/feel like vomiting-riding bike in esophagus; indigestion; diarrhea; Slight headache on injection day; This is a spontaneous report from a contactable consumer reporting for himself. A 65-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the right arm on 30Jan2021 08:30 AM at single dose for COVID-19 immunization in a hospital. Medical history included hypertension, anxiety and penicillin allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified medications received within two weeks of vaccination. The patient experienced slight headache on injection day. The patient experienced nausea and indigestion leading to diarrhea and feel like vomiting - riding bike in esophagus on 31Jan2021 at 01:00 AM. The patient did not receive any treatment for the events. The reporter assessed the events as non-serious. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 1067977
Sex: F
Age:
State:

Vax Date: 01/29/2021
Onset Date:
Rec V Date: 03/03/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: pain; inflammation,; This is a spontaneous report from a Pfizer-sponsored program, received from a contactable consumer, reporting for herself. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 29Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced pain and inflammation. She was concerned about taking Advil and/or Tylenol after her surgery on Monday. She has not taken those medications yet, however, she asked if taking them for any pain or inflammation, could that interfere with the immunization process of her vaccination. The outcome of the events was unknown. Information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1067978
Sex: F
Age:
State: TX

Vax Date:
Onset Date: 01/31/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Vomiting; vertigo; headache; This is a spontaneous report from a contactable patient (consumer). female patient of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration on the left arm, at age 37 years, first dose on an unspecified date, at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced vomiting, vertigo and headache on 31Jan2021 10:00. Facility where the most recent COVID-19 vaccine was administered was at a Administration facility. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Treatment was not received for the adverse event. Since the vaccination, the patient has nor been tested for COVID-19. The outcome of the event was not recovered. Case was reported as non-serious. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1067979
Sex: F
Age:
State:

Vax Date: 01/18/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: chills; congestion; achiness; runny nose; pain around the sinuses; fever; cough; tired; low appetite; sneezing; headache; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on 18Jan2021 at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient developed symptoms 11 days after her first dose. On 29Jan2021, she reported Chills, Congestion, Achiness, Runny nose, Pain around the Sinuses, Fever, Cough, Tired, Low appetite, Sneezing and Headache. The patient wanted to know if these side effects were reported with Pfizer Covid-19 vaccine. The patient also asked if she can I still develop COVID-19 infection after receiving the first dose. Also, if the vaccine cause a false positive COVID-19 test. She also asked what was the timing of the 2nd dose of vaccine and if she can get the second dose 21 days after dose 1. The patient also asked if both doses of Pfizer COVID-19 vaccine are identical. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1067980
Sex: F
Age:
State: VA

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: diarrhea/ Stools loose; This is a spontaneous report from a contactable consumer (patient). A 90-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EN5318), via an unspecified route of administration into the left arm on 30Jan2021 13:00 at a single dose for COVID-19 immunisation. Medical history included metastatic thyroid cancer and ventilator/oxygen/feeding tube dependent. Patient was not pregnant. Concomitant medication included metoprolol (METOPROLOL), furosemide (LASIX), valacyclovir (VALACYCLOVIR), bifidobacterium lactis (PROBIOTIC) and cetirizine hydrochloride (CETIRIZ). On 30Jan2021 13:30, patient experienced diarrhea; also reported as stools loose. The event was reported as non-serious and the patient was treated with loperamide. Outcome of event was recovering.

Other Meds: METOPROLOL; LASIX [FUROSEMIDE]; VALACYCLOVIR [VALACICLOVIR]; PROBIOTIC; CETIRIZ

Current Illness:

ID: 1067981
Sex: F
Age:
State: TX

Vax Date: 01/29/2021
Onset Date: 01/01/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: very active stomach, diarrhea due to problem (nervous)/bowel movement really often; very active stomach, diarrhea due to problem (nervous)/bowel movement really often; Stool being dark is concerning; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received second dose of bnt162b2 (BNT162B2 also reported as PFIZER-BIONTECH COVID-19 VACCINE, lot EL8982), intramuscular in right arm on 29Jan2021 at SINGLE DOSE for Covid-19 immunisation. Medical history included high blood pressure and had insulin resistance. She had her first dose of BNT162B2 on 03Jan2021. Concomitant medication included metformin. She also mentioned 'Candistan Clotrimazole' (not clear nor clarified) something like that, and also took 'Premarin' (not clear nor clarified) it's hormone for menopause. She got the vaccine instead of 21 days it was 26 days. Since when she had the vaccine, her stomach was really active, diarrhea due to problem (nervous). She informed having bowel movements like really often. Today (Jan2021), she already went twice but the thing was she was going and it was like too dark, mentioned that stool being dark was concerning. She took Libertrim S11 Trimebutine Simethicone, for diarrhea. The outcome of events was unknown.

Other Meds: METFORMIN

Current Illness:

ID: 1067982
Sex: M
Age:
State: WA

Vax Date: 01/21/2021
Onset Date: 01/26/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: slight fatigue the next day; some left arm soreness; This is a spontaneous report from a contactable consumer (reported for himself). A 79-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot EL 9261, expiry date not reported), via an unspecified route of administration on 21Jan2021 at a single dose in the left arm for COVID-19 immunization. Medical history included high blood pressure, a-fib, small stroke 5 years ago and some weakness from that (stroke). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications included atenolol, amlodipine, warfarin, and lisinopril. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in the hospital. On 26Jan2021, patient experienced slight fatigue the next day (as reported) and some left arm soreness. No treatments received in response to the events reported. The events were reported as not serious (did not result in death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating and not a congenital anomaly/birth defect). Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events fatigue and left arm soreness was recovered in Jan2021.

Other Meds: ATENOLOL; AMLODIPINE; WARFARIN; LISINOPRIL

Current Illness:

ID: 1067983
Sex: F
Age:
State: MN

Vax Date: 01/30/2021
Onset Date: 01/31/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Fever over 100; headache; chills; joint soreness; arm soreness; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9264, expiration date was not reported), via an unspecified route of administration on the left arm on 30Jan2021 14:00 at single dose for COVID-19 immunization. Medical history included Sulfa allergy, penicillin allergy, COVID-19 (Prior to vaccination, was the patient diagnosed with COVID-19). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included estradiol. The patient experienced fever over 100, headache, chills, joint soreness and arm soreness on 31Jan2021 at 04:00 am. No treatment was given in response to the events. Outcome of the events was unknown.

Other Meds: ESTRADIOL

Current Illness:

ID: 1067984
Sex: F
Age:
State: VA

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: headache on right side of head; back went out from right side and cannot bend over; right leg hurts; right foot tingles; This is a spontaneous report from a contactable other healthcare professional (patient). A 50-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL3246) via an unspecified route of administration on the right arm on 29Jan2021 10:00 at a single dose for COVID-19 immunization. Medical history included patient diagnosed with COVID-19 prior to vaccination. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162B2 on 06Jan2021 for COVID-19 immunization (lot number: EK4176, administration time: 02:00 PM on left arm). The patient previously took levofloxacin (LEVAQUIN) and cefalexin (KEFLEX) and experienced allergies to medications. On 30Jan2021 10:00 PM, the patient experienced headache on right side of head, back went out from right side and cannot bend over, right leg hurts and right foot tingles. No fever. No treatment was received for the adverse events. Events were reported as non-serious: did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. The facility where the vaccine was administered was in a hospital. Patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 1067985
Sex: M
Age:
State: FL

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: joint pain in his big toe on his left foot; This is a spontaneous report from a contactable consumer (patient himself). A 77-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EL9262, NDC/UPC number and expiry date were unknown), via an unspecified route of administration in the left deltoid (also reported as the left shoulder) on 29Jan2021 at 09:30 AM at a single dose for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was reported as the public health clinic/veterans administration facility. Relevant medical history included sleep problem. The patient had no allergies to medications, food, or other products. Concomitant medication included promethazine (strength: 25 mg) for sleep problem. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had the Pfizer COVID vaccine shot on Friday morning, on 29Jan2021, and later that day by the evening, he started to experience some joint pain in his big toe on his left foot and the pain had not changed or gone away since then. The patient assessed the event as non-serious. The adverse event did not require any visit to the physician office or emergency room. The patient further stated that he haven't done anything. It happened on Friday and it was there the day prior reporting (yesterday), and it was there in the morning at the time of the report, and the patient was just kind of waiting to see if it would get any better. So, he haven't done anything and was asking what he should do about that. Therapeutic measures were taken as a result of joint pain in his big toe on his left foot, which included that the patient took some paracetamol (TYLENOL), but it didn't really seem to help much, so he didn't take anymore. The patient had no investigation assessment. The patient was not recovered from the event.

Other Meds: PROMETHAZINE

Current Illness:

ID: 1067986
Sex: F
Age:
State: FL

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: tenderness in area of injection; noted blotchy redness, no pain, extending 6 in below shot site; This is a spontaneous report from a contactable consumer who reported for herself. A 74-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EL 9263) via an unspecified route of administration on 29Jan2021 at 19:30 (at the age of 74-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included HTN (hypertension), atherosclerosis, hip replacement, TIA (transient ischemic attack) and "INCR" lipids (increased lipids), all from unspecified dates and unspecified if ongoing. The patient had no known allergies to mediations, food or other products. Concomitant medications (received within 2 weeks of vaccination) included nebivolol hydrochloride (BYSTOLIC), lisinopril, calcium citrate (CITRACAL), ezetimibe (ZETIA) and pitavastatin calcium (LIVALO), all taken for unspecified indications on unspecified dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient experienced tenderness in area of injection and noted blotchy redness, no pain, extending 6 in below shot site, both on 29Jan2021 at 23:00, both reported as non-serious. The events did not cause hospitalization. The clinical course was reported as follows: "tenderness in area of injection began hours after injection and increased over 24hrs and began to decease. 52hrs p shot noted blotchy redness, no pain, extending 6 in below shot site. Still there 18hrs later but fading in color." No treatment was received for the events. It was reported that it was unknown whether the patient was recovered. The clinical outcomes of the events tenderness in area of injection and noted blotchy redness, no pain, extending 6 in below shot site were both unknown.

Other Meds: BYSTOLIC; LISINOPRIL; CITRACAL; ZETIA; LIVALO

Current Illness:

ID: 1067987
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: neck pain (base of skull); neck stiffness; nausea; hot flashes; general fatigue; feeling unwell; sick; This is a spontaneous report from a non-contactable consumer (patient). A 22-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at time of vaccination. The patient was previously vaccinated with first dose of BNT162B2 on unspecified date at single use for COVID-19 immunization. The patient experienced neck pain (base of skull) / neck stiffness, nausea, hot flashes, general fatigue, feeling "unwell" and was sick on an unspecified date. The outcome of the events was recovered on unspecified date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events were considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, were not disabling/Incapacitating and were not a congenital anomaly/birth defect. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1067988
Sex: F
Age:
State: CA

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: heart rate suddenly increased; throat felt tight; felt very warm in the head and neck like was flushed; felt very warm in the head and neck like was flushed; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient). A 41-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EL9265) via an unspecified route of administration in the left arm on 30Jan2021 10:30 am at a single dose as Covid vaccine. Medical history included known allergies to penicillin- anaphylaxis. There were no concomitant medications (no other vaccine in four weeks and no other medications in two weeks). Approximately 5 minutes after injection, heart rate suddenly increased and throat felt tight, and felt very warm in the head and neck like was flushed on 30Jan2021 10:45 am. It passed after a minute or two, then happened again around five times within the hour after injection. No treatment was provided for the events. The patient had no Covid prior to vaccination and has not had Covid tested positive post vaccination. The outcome of the events was recovered on Jan2021.

Other Meds:

Current Illness:

ID: 1067989
Sex: M
Age:
State: MO

Vax Date: 12/23/2020
Onset Date: 01/09/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Blurry Vision; Headaches; Left ear pain; Loss of taste, smell; Loss of taste, smell; Insomnia; Fatigue; Joint pain; Neck pain; This is a spontaneous report from a contactable consumer reporting for himself. A 51-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number and expiration date not provided, via an unspecified route of administration on 23Dec2020 at a single dose for COVID-19 immunisation. Medical history included allergies to penicillin and COVID-19 prior to vaccination. Historical vaccine included first dose of BNT162B2 on an unspecified date for COVID-19 immunization. Concomitant medication included unspecified drug. On 09Jan2021, the patient experienced blurry vision, headaches, left ear pain, loss of taste and smell, insomnia, fatigue, joint pain and neck pain. The patient received meloxicam as treatment medication. The events were considered as non-serious. The outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1067990
Sex: F
Age:
State: CA

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: slight swelling; arm redness at injection site; chills; fever 103.8; weakness; headache; This is a spontaneous report from a contactable other health professional (patient). A 58-year-old female non-pregnant patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) lot number EL9262 and expiry date unknown, via unspecified route of administration at the left arm on 28Jan2021 11:15 at single dose for Covid-19 immunization in a hospital. Medical history included high blood pressure, depression, asthma, wheat allergies. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included lisinopril, paroxetine hydrochloride (PAXIL [PAROXETINE HYDROCHLORIDE]), cyanocobalamin (VIT B12), ergocalciferol (VIT D); all from unspecified date for unspecified indication. The patient previously took amoxicilin, morphine, vicodin; all experienced drug allergy. Historical vaccine included first dose of BNT162B2 lot number EH9899 at the left arm on 07Jan2021 11:15 AM for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 28Jan2021 19:00, the patient experienced chills, fever 103.8 (temperature), weakness, headache, until 30Jan2021 6:30 am. Then again, on 30Jan2021 11 pm, the patient experienced fever, chills headache until 6:30 am. On 30Jan2021, the patient experienced arm redness at injection site. On 31Jan2021, the patient continued to experience redness and slight swelling (injection site). The patient has the patient been tested for COVID-19 since the vaccination. The patient did not received treatment for the events. The outcome of the events was recovering. The reporter considered the events non-serious; did not results in death, was not life threatening, did not cause/prolong hospitalization, was not disabling/incapacitating, and no congenital anomaly/birth defect.

Other Meds: LISINOPRIL; PAXIL [PAROXETINE HYDROCHLORIDE]; VIT B12; VIT D

Current Illness:

ID: 1067991
Sex: F
Age:
State: FL

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Covid test with nasal swab last week and it came back positive; Covid test with nasal swab last week and it came back positive; This is a spontaneous report from a contactable consumer (husband). A 67-year-old female patient (wife) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in the right arm on 09Jan2021 at a single dose as Covid-19 vaccine. There were no medical history and no concomitant medications. The reporter called and stated that he and his wife received the first dose of the Pfizer-BioNtech Covid-19 vaccine 3 weeks ago on 09Jan2021, they were ready to receive the second dose of the vaccine; however, last week his wife took a nose swab test and she was positive for Covid-19 on Jan2021. The patient did not visit physician office/emergency room. She felt fine. They would like to know if they could receive the second dose or if they should wait. They had the first shot (Covid-19 Vaccine by Pfizer) he and his wife, and they have an adult child living with them, he didn't qualify because of the age. Their 3 weeks were up and they had been notified to get the second shot, he and his wife, now in between she took a Covid test with nasal swab last week and it came back positive, could they still take it, the second shot? And then what were the chances with them having the first shot, was why she tested positive? No treatment was received for the events. The outcome of the events was unknown. Information on the lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 1067992
Sex: F
Age:
State: MO

Vax Date: 01/27/2021
Onset Date: 01/31/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Fever; Migraine; Nausea; Throwing up; This is a spontaneous report from a contactable healthcare professional (patient). A 32-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot: EL3247), intramuscular on the left arm (at the age of 32years) on 27Jan2021 at 14:00 at single dose for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included migraines, kidney stones and high cholesterol. The patient had no allergies to medications, food, or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. The reported adverse events were fever, migraine, nausea, and throwing up on 31Jan2021 with no treatment received on all events. The patient considered the events as non-serious. Did not results in death, non- life threatening, did not cause/prolong hospitalization, non-disabling/incapacitating and no congenital anomaly/birth defect. The outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 1067993
Sex: F
Age:
State: WI

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: light headed; slight headache; tired; Upper arm became sore and a bit swollen/Upper arm more swollen and sore.; Upper arm became sore and a bit swollen/Upper arm more swollen and sore.; Did not sleep well overnight (always do) and woke up very tired; sick to stomach; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL3248, expiry date not reported), via an unspecified route of administration in the left arm on 30Jan2021 15:00 at single dose for COVID-19 immunization. Medical history included Raynaud's phenomenon. Concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a hospital. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient previously received fluvastatin sodium (LESCOL) and experienced drug hypersensitivity, and nifedipine (ADALAT) and experienced drug hypersensitivity. On 30Jan2021 17:30, in the evening the patient became light headed, had a slight headache and was tired. Her upper arm became sore and a bit swollen. She did not sleep well overnight (always do) and woke up very tired, sick to stomach. Her upper arm was more swollen and sore. No therapeutic measures was taken as a result of the events. Clinical outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 1067994
Sex: F
Age:
State: DC

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Injection site pain; Chills; nausea; fever 99.5; This is a spontaneous report from a contactable consumer. A 50-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on the right arm on 30Jan2021 10:00 at a single dose for COVID-19 immunization in a clinic. Medical history included high blood pressure and COVID-19 prior to vaccination. The patient was not pregnant. Concomitant medication included hydrochlorothiazide, lisinopril hydrochlorthiazid, loratadine, and fluticasone propionate (FLONASE). The patient experienced injection site pain, chills, nausea, fever 99.5 on 30Jan2021 10:00. The patient did not receive any treatment for the events. The patient was recovering from the events. Information on lot/ batch number has been requested.

Other Meds: LISINOPRIL HYDROCHLORTHIAZID; LORATADINE; FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 1067995
Sex: F
Age:
State: TX

Vax Date: 01/23/2021
Onset Date: 01/01/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Very dizzy (room spinning falling)/ Dizziness; Dry heaves; Briefly queasy; Brief feeling of coming down with cold; Sinus swelling; Quickly fatigued still here a week later; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number and expiry date not reported), via an unspecified route of administration at the right arm on 23Jan2021 09:45 at single dose for COVID-19 immunization. Medical history included environmental allergies (many), gastrooesophageal reflux disease, atrial tachycardia, blood pressure abnormal, cholecystectomy, hysterectomy, retinopexy, cellulitis, sepsis and pneumonia from an unknown date and unknown if ongoing. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has been tested for COVID-19. Concomitant medications included diltiazem, dexlansoprazole (DEXILANT), flecainide, hctz , and triamterene. The patient previously received and experienced allergies from ciprofloxacin hydrochloride (CIPRO), cefalexin (KEFLEX), tetracycline, sulfamethoxazole, trimethoprim (BACTRIM), glycopyrronium bromide (ROBINUL), doxycycline (DORYX), loratadine (CLARITIN), tetracycline hydrochloride (SUMYCIN), lisinopril and clindamycin hydrochloride (CLEOCIN). On the day of shot, on 23Jan2021 10:15 had a brief feeling of coming down with cold. Next day on 24Jan2021, the patient experienced briefly queasy, 3rd day fine, 4th day very dizzy (room spinning falling) and dry heaves. The patient also experienced dizziness, sinus swelling, and fatigued still here a week later. She took weekly immunotherapy shots for her multiple allergies. The patient underwent lab tests and procedures which included SARS-COV-2 test: negative on 28Jan2021. Therapeutic measure was taken for all the events. Clinical outcome of the events was not recovered. Information about lot/batch number has been requested.

Other Meds: DILTIAZEM; DEXILANT; FLECAINIDE; HCTZ; TRIAMTERENE

Current Illness:

ID: 1067996
Sex: M
Age:
State: CA

Vax Date: 01/26/2021
Onset Date: 01/27/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: general feeling of unwellness; chill; headache; loss of balance; This is a spontaneous report from a contactable consumer (reported for himself). An 83-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot EL9262, expiry date not reported), via an unspecified route of administration on 26Jan2021 10:30 at a single dose in the left arm for Covid-19 immunization. The patient's medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications included quinapril at 5 mg, cyanocobalamin (B-12) at 2500 ug (2500 mcg), and atorvastatin at 40 mg. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Jan2021 08:00 pm, patient experienced a general feeling of unwellness, chill, headache, and loss of balance. The events were reported as not serious (did not result in death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating and not a congenital anomaly/birth defect). Since the vaccination, the patient had not been tested for COVID-19. No treatment received for the adverse events. The events recovered on an unspecified date in 2021.

Other Meds: QUINAPRIL; B-12; ATORVASTATIN

Current Illness:

ID: 1067997
Sex: F
Age:
State: WI

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Uncontrollable chills; stabbing pain all over; headaches; body shakes; nausea; sensitivity to smells; motion; tired; This is a spontaneous report from a contactable healthcare professional. A 54-year-old female patient received the second dose of BNT162B2 (Pfizer-BIONTECH COVID-19 Vaccine; Lot number: T23248), intramuscular in the left arm on 29Jan2021 at 10:00 AM as a single dose for COVID-19 immunization. Medical history included known allergies to sulfa. The patient did not have COVID prior to vaccination, had no other vaccine in four weeks and was not pregnant at the time of vaccination. Concomitant medications included multivitamins, ibuprofen, and paracetamol (TYLENOL). The patient received the first dose of BNT162B2 on 10Jan2021. On 29Jan2021 at 07:00 PM, the patient experienced uncontrollable chills, stabbing pain all over, headaches, body shakes, nausea, sensitivity to smells, "motion", and tired. The patient was not COVID tested after vaccination. The patient received no treatment for the events. Outcome of the events was recovering.

Other Meds: IBUPROFEN; TYLENOL

Current Illness:

ID: 1067998
Sex: F
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: lot of pain went around muscle shoulder pain; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration, first dose on Jan2021 at single dose for COVID-19 vaccination. The patient's medical history and concomitant medications were not reported. The patient experienced a lot of pain went around muscle shoulder pain on Jan2021. Patient took a paracetamol (TYLENOL) and takes aspirin. Patient was asking if it will reduce efficacy of vaccine dose and indicated that she will take second dose. The outcome of the event was unknown. Information about lot/batch has been requested.

Other Meds:

Current Illness:

ID: 1067999
Sex: F
Age:
State: FL

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Pain in arm; This is a spontaneous report from a contactable consumer (patient herself). A 72-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: 1284, expiration date was unknown), via an unspecified route of administration in the left arm on 07Jan2021 at 16:00 at a single dose for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was the hospital. The patient's medical history and concomitant medications were not reported. The patient had no allergies to medications, food, or other products. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Jan2021 at 16:00, the patient experienced pain in arm, which was still bad after more than 3 weeks. The patient assessed the event as non-serious. Therapeutic measures were taken as a result of pain in arm, which included paracetamol (TYLENOL) or ibuprofen (ADVIL). The patient was not recovered from the event.

Other Meds:

Current Illness:

ID: 1068000
Sex: F
Age:
State: AZ

Vax Date: 01/28/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Fever; chills; cold sweats; extremely achy body to the point where it was difficult to lift myself out of bed; extremely achy body to the point where it was difficult to lift myself out of bed; I also had extreme fatigue; I slept for almost 20 hours straight, and slept through work without waking up to call out; This is a spontaneous report from a contactable other healthcare professional reporting for herself. A 34-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1238), intramuscular from 28Jan2021 15:45 (03:45 PM), (at the age of 34-years-old) at single dose on left arm for COVID-19 immunization. Patient was not pregnant at time of vaccination. Medical history included bipolar 2 disorder (reported as "ipolar 2 disorder") and attention deficit hyperactivity disorder (ADHD). Patient has no allergies to medications, food and other products. Patient was not diagnosed with COVID-19 prior vaccination. Concomitant medications (other medications the patient received within 2 weeks of vaccination) included lamotrigine (100 mg), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL; reported as "Adderall XR 15 mg") and quetiapine fumarate (50 mg). Patient did not received any other vaccines within 4 weeks prior vaccination. Facility where the most recent COVID-19 vaccine was administered was reported as "Other". The patient received first dose of COVID-19 vaccine on 07Jan2021 01:00 PM (lot number: EH9899), intramuscular on the left arm. On 29Jan2021 02:00 AM, the patient experienced fever, chills, cold sweats, extremely achy body to the point where it was difficult to lift herself out of bed. The patient also had extreme fatigue. Patient slept for almost 20 hours straight, and slept through work without waking up to call out. No treatment was received for the events. The events were assessed as non-serious. Outcome of the events was recovered in 2021. Body temperature on 29Jan2021 with unknown results. Since the vaccination, the patient has not been tested for COVID-19

Other Meds: LAMOTRIGINE; ADDERALL; QUETIAPINE FUMARATE

Current Illness:

ID: 1068001
Sex: F
Age:
State: WI

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Left arm soreness; This is a spontaneous report from a contactable nurse (reporting for herself). A 51-year-old female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982), via an unspecified route of administration from 28Jan2021 14:45 to 28Jan2021 14:45 at SINGLE DOSE for covid-19 immunization. The patient's medical history included Environmental allergies: some trees and grass. Concomitant medication included bupropion hydrochloride (WELLBUTRIN), loratadine, pseudoephedrine sulfate (CLARITIN-D), montelukast sodium (SINGULAIR), diphenhydramine hydrochloride (BENADRYL), colecalciferol (VITAMIN D [COLECALCIFEROL]), all for unspecified indication. The previously took her first dose of bnt162b2 on 07Jan2021 (lot number: EL3248) on her left arm for covid-19 immunization. On 28Jan2021 at 17:30, the patient experienced Left arm soreness beginning a few hours after vaccine administration and lasting about another 24 hours. The outcome of the event was recovered on an unspecified date. The seriousness of the event was reported as non-serious. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination.

Other Meds: WELLBUTRIN; CLARITIN-D; SINGULAIR; BENADRYL; VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 1068002
Sex: F
Age:
State: GA

Vax Date: 01/25/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: My face broke out in hives; My face broke out in hives/were itchy and hot/ itching; My face broke out in hives/were itchy and hot; This is a spontaneous report from a contactable consumer (patient). A 27-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3247; expiry date: unknown) via an unspecified route of administration in the left arm, on 25Jan2021 at 09:00, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) in the left arm on 04Jan2021 for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On Friday, 30Jan2021 at 11:00, the patient's face broke out in hives. They were itchy and hot, and it was sudden, over the course of 15 to 30 minutes after the itching, they appeared. The patient took cetirizine hydrochloride before bed and applied cooling balm. The hives were gone this morning. The events were considered non-serious. Outcome of the events was recovered. The patient has not been tested for COVID-19 since vaccination.

Other Meds:

Current Illness:

ID: 1068003
Sex: M
Age:
State: FL

Vax Date: 01/28/2021
Onset Date: 01/29/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Severe dizziness; Felt tired; off kilter; nausea; This is a spontaneous report from a contactable consumer (patient). A 79-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiration date unknown), via an unspecified route of administration in the left arm on 28Jan2021 15:00 at a single dose for covid-19 immunization at a Administration facility. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with Covid-19 prior to vaccination. The patient has no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced severe dizziness upon awaking the following day (29Jan2021), which lessened as the day wore on. The patient also felt tired and off kilter all day with nausea from midday to night. The patient has not been tested for COVID-19 since the vaccination. The events were not treated. The outcome of the events was recovered on an unspecified date. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1068004
Sex: F
Age:
State: MI

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: raised bump on arm at injection site; Chest pain; This is a spontaneous report from a contactable consumer reported for herself (also reported as nurse). A 69-year-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9261, expiration date unknown) via an unspecified route of administration on the left arm on 25Jan2021 at 12:15 PM at a single dose for COVID-19 immunisation in the hospital. Medical history included asthma and hypertension (controlled), sulfa allergy all from an unknown date. Concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR), montelukast sodium (SINGULAIR), simvastatin and spironolactone. The patient previously took propylene glycol and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient experienced well defined raised bump on arm at injection site and chest pain both on 25Jan2021. It was reported that chest pain on the evening of 30Jan2021 resolved after 45 minutes after taking 2 aspirin, followed by 2 more after 30 minutes. The events were assessed as non-serious by the reporter. The patient was recovering from well defined raised bump on arm at injection site and chest pain. The patient has not been tested for COVID-19 since the vaccination.

Other Meds: ADVAIR; SINGULAIR; SIMVASTATIN; SPIRONOLACTONE

Current Illness:

ID: 1068005
Sex: F
Age:
State: MD

Vax Date: 01/13/2021
Onset Date: 01/15/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: rash on right breast; swollen and painful axillary lymph node; swollen and painful axillary lymph node; This is a spontaneous report from a contactable healthcare professional (patient). A 28-year-old non-pregnant female patient received her second dose of bnt162b2 (BNT162B2 reported as COVID-19 vaccine; lot number: ek5730; expiration date: unknown) at the vaccination age of 28-year-old via an unspecified route of administration in the right arm on 13Jan2021 10:00 at a single dose for covid-19 immunisation. The patient medical history was not reported. The patient diagnosed with COVID-19 prior to vaccination. The patient has no allergies to medications, food, or other products. Concomitant medication included duloxetine hydrochloride (CYMBALTA), ibuprofen (ADVIL) and birth control medication. The patient first dose of bnt162b2 (BNT162B2 reported as COVID-19 vaccine; lot number: ek5730) at the vaccination age of 28-year-old via an unspecified route of administration in the right arm on 13Jan2021 10:00 at a single dose for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the most recent COVID-19 vaccine in a hospital. On 15Jan2021, the patient had rash on right breast, and swollen and painful axillary lymph node. The patient did not receive treatment for the adverse events. The events were non-serious, and the events resulted in doctor or other healthcare professional office/clinic visit. The patient has not been tested for COVID-19 since the vaccination. The outcome of the events was not recovered.

Other Meds: CYMBALTA; ADVIL [IBUPROFEN]

Current Illness:

ID: 1068006
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: cold; I have a little cough; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age (reported as 85, unit unknown) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, it was reported that the patient was asking if he can get the 2nd dose of vaccine if he "has a cold". The patient also reported that "I have a little cough and I want to know if it is alright for me to take my second shot, I was supposed to take it in the morning, I have a cough and I wanted to know if is it all right me to take my second shot. I have a cold is it alright to take my second shot." The outcome of the events was unknown. Information on lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 1068007
Sex: M
Age:
State:

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 03/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: dizziness; This is a spontaneous report received from a contactable consumer (patient). A male patient of an unspecified age (reported as "72", unit not provided) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), intramuscular, on 30Jan2021, at single dose, for COVID-19 immunization. Medical history included vertigo (reported as "vertigo real bad"). Concomitant medication included an unspecified blood thinner. On 30Jan2021, almost right away, the patient experienced dizziness. The patient was unsure if his dizziness was from the vaccine or from his history of vertigo. The patient also reported that he is taking a blood thinner and was not aware he needed to let his vaccination provider know until after he got his dose. He asked if he should be concerned. The outcome of the event was unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm